Sign Up Today and Learn More About Ginkgo Bioworks Stock
Invest in or calculate the value of your shares in Ginkgo Bioworks or other pre-IPO companies through EquityZen's platform.
Ginkgo Bioworks Stock
Custom Microbes Design
Ginkgo Bioworks is a biotech company that designs custom microbes. The company creates custom microbes for three main areas: cultured ingredients, strain improvement, and enzymes. For cultured ingredients, Ginkgo Bioworks creates engineered yeasts to produce ingredients via fermentation for perfumes, foods, cosmetics, etc. For strain improvement, Ginkgo Bioworks engineers in-use organisms to improve efficiency and sustainability. For enzymes, Ginkgo Bioworks aims to discover "better" enzymes for various applications, such as cheesemaking and pharmaceuticals. Ginkgo Bioworks' platform consists of its Foundries and Codebase. Foundries are Ginkgo Bioworks way to automate organism design and Codebase is Ginkgo Bioworks' library of cell, enzyme and genetic programs that help jumpstart new programs and discoveries. Ginkgo Bioworks was founded in 2009. The company is based in Boston, Massachusetts.
About Ginkgo Bioworks Stock
Founded
2008
Headquarters
Boston, MA, US
Total Funding
1.1B
Industries
Science and Engineering, Health Care, Biotechnology
Ginkgo Bioworks is a biotech company that designs custom microbes. The company creates custom microbes for three main areas: cultured ingredients, strain improvement, and enzymes. For cultured ingredients, Ginkgo Bioworks creates engineered yeasts to produce ingredients via fermentation for perfumes, foods, cosmetics, etc. For strain improvement, Ginkgo Bioworks engineers in-use organisms to improve efficiency and sustainability. For enzymes, Ginkgo Bioworks aims to discover "better" enzymes for various applications, such as cheesemaking and pharmaceuticals.
Ginkgo Bioworks' platform consists of its Foundries and Codebase. Foundries are Ginkgo Bioworks way to automate organism design and Codebase is Ginkgo Bioworks' library of cell, enzyme and genetic programs that help jumpstart new programs and discoveries.
Ginkgo Bioworks was founded in 2009. The company is based in Boston, Massachusetts.
Ginkgo Bioworks Press Mentions
Stay in the know about the latest news on Ginkgo Bioworks
Exclusive: Ginkgo teams with unknown upstart in hunt for Covid-19 antibody
endpts • Sep 10, 2020
Synthetic biology startups are giving investors an appetite
TechCrunch • Aug 26, 2020
Ginkgo Receives $70M Investment
finsmes • May 28, 2020
Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus
Wall Streets Journal • Apr 30, 2020
Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response
PR Newswire • Apr 15, 2020
Investors in Ginkgo Bioworks
Discover investors in Ginkgo Bioworks stock and explore their portfolio companies
Ginkgo Bioworks Management
Leadership team at Ginkgo Bioworks
Chief Executive Officer
Jason Kelly
Co-Founder
Barry Canton
Join now and verify your accreditation status to gain access to:
- Ginkgo Bioworks current valuation
- Ginkgo Bioworks stock price
- Available deals in Ginkgo Bioworks and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Ginkgo Bioworks stock?
Accredited investors can buy pre-IPO stock in companies like Ginkgo Bioworks through EquityZen funds. These investments are made available by existing Ginkgo Bioworks shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ginkgo Bioworks stock?
Shareholders can sell their Ginkgo Bioworks stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
